Validation of the Oxford classification of IgA nephropathy for pediatric patients from China
<p>Abstract</p> <p>Background</p> <p>The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations.<...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-11-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2369/13/158 |
id |
doaj-42d4f54418864a9d9bdadfafd6e5f163 |
---|---|
record_format |
Article |
spelling |
doaj-42d4f54418864a9d9bdadfafd6e5f1632020-11-25T00:37:15ZengBMCBMC Nephrology1471-23692012-11-0113115810.1186/1471-2369-13-158Validation of the Oxford classification of IgA nephropathy for pediatric patients from ChinaLe WeiboZeng Cai-HongLiu ZhangsuoLiu DongYang QingLin Rui-XiaXia Zheng-KunFan Zhong-MinZhu GuanghuaWu YingXu HongZhai YihuiDing YingYang XiaoqingLiang ShaoshanChen HaoXu FengHuang QianShen HongbingWang JianmingFogo Agnes BLiu Zhi-Hong<p>Abstract</p> <p>Background</p> <p>The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations.</p> <p>Methods</p> <p>A total of 218 children with IgAN from 7 renal centers in China were enrolled. The inclusion criteria was similar to the original Oxford study.</p> <p>Results</p> <p>There were 98 patients (45%) with mesangial proliferation (M1), 51 patients (23%) with endocapillary proliferation (E1), 136 patients (62%) with segmental sclerosis/adhesion lesion (S1), 13 patients (6%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred), and only 2 patients (1%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). During a median follow-up duration of 56 months, 24 children (12.4%) developed ESRD or 50% decline in renal function. In univariate COX analysis, we found that tubular atrophy/interstitial fibrosis (HR 4.3, 95%CI 1.8-10.5, P < 0.001) and segmental glomerulosclerosis (HR 9.2 1.2-68.6, P = 0.03) were significant predictors of renal outcome. However, mesangial hypercellularity, endocapillary proliferation, crescents, and necrosis were not associated with renal prognosis. In the multivariate COX regression model, none of these pathologic lesions were shown to be independent risk factors of unfavorable renal outcome except for tubular atrophy/interstitial fibrosis (HR 2.9, 95%CI 1.0-7.9 P = 0.04).</p> <p>Conclusions</p> <p>We confirmed tubular atrophy/interstitial fibrosis was the only feature independently associated with renal outcomes in Chinese children with IgAN.</p> http://www.biomedcentral.com/1471-2369/13/158GlomerulonephritisIgA nephropathyOxford classificationChildrenPediatrics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Le Weibo Zeng Cai-Hong Liu Zhangsuo Liu Dong Yang Qing Lin Rui-Xia Xia Zheng-Kun Fan Zhong-Min Zhu Guanghua Wu Ying Xu Hong Zhai Yihui Ding Ying Yang Xiaoqing Liang Shaoshan Chen Hao Xu Feng Huang Qian Shen Hongbing Wang Jianming Fogo Agnes B Liu Zhi-Hong |
spellingShingle |
Le Weibo Zeng Cai-Hong Liu Zhangsuo Liu Dong Yang Qing Lin Rui-Xia Xia Zheng-Kun Fan Zhong-Min Zhu Guanghua Wu Ying Xu Hong Zhai Yihui Ding Ying Yang Xiaoqing Liang Shaoshan Chen Hao Xu Feng Huang Qian Shen Hongbing Wang Jianming Fogo Agnes B Liu Zhi-Hong Validation of the Oxford classification of IgA nephropathy for pediatric patients from China BMC Nephrology Glomerulonephritis IgA nephropathy Oxford classification Children Pediatrics |
author_facet |
Le Weibo Zeng Cai-Hong Liu Zhangsuo Liu Dong Yang Qing Lin Rui-Xia Xia Zheng-Kun Fan Zhong-Min Zhu Guanghua Wu Ying Xu Hong Zhai Yihui Ding Ying Yang Xiaoqing Liang Shaoshan Chen Hao Xu Feng Huang Qian Shen Hongbing Wang Jianming Fogo Agnes B Liu Zhi-Hong |
author_sort |
Le Weibo |
title |
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China |
title_short |
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China |
title_full |
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China |
title_fullStr |
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China |
title_full_unstemmed |
Validation of the Oxford classification of IgA nephropathy for pediatric patients from China |
title_sort |
validation of the oxford classification of iga nephropathy for pediatric patients from china |
publisher |
BMC |
series |
BMC Nephrology |
issn |
1471-2369 |
publishDate |
2012-11-01 |
description |
<p>Abstract</p> <p>Background</p> <p>The Oxford classification of IgA nephropathy (IgAN) provides a useful tool for prediction of renal prognosis. However, the application of this classification in children with IgAN needs validation in different patient populations.</p> <p>Methods</p> <p>A total of 218 children with IgAN from 7 renal centers in China were enrolled. The inclusion criteria was similar to the original Oxford study.</p> <p>Results</p> <p>There were 98 patients (45%) with mesangial proliferation (M1), 51 patients (23%) with endocapillary proliferation (E1), 136 patients (62%) with segmental sclerosis/adhesion lesion (S1), 13 patients (6%) with moderate tubulointerstitial fibrosis (T1 26-50% of cortex scarred), and only 2 patients (1%) with severe tubulointerstitial fibrosis (T2, >50% of cortex scarred). During a median follow-up duration of 56 months, 24 children (12.4%) developed ESRD or 50% decline in renal function. In univariate COX analysis, we found that tubular atrophy/interstitial fibrosis (HR 4.3, 95%CI 1.8-10.5, P < 0.001) and segmental glomerulosclerosis (HR 9.2 1.2-68.6, P = 0.03) were significant predictors of renal outcome. However, mesangial hypercellularity, endocapillary proliferation, crescents, and necrosis were not associated with renal prognosis. In the multivariate COX regression model, none of these pathologic lesions were shown to be independent risk factors of unfavorable renal outcome except for tubular atrophy/interstitial fibrosis (HR 2.9, 95%CI 1.0-7.9 P = 0.04).</p> <p>Conclusions</p> <p>We confirmed tubular atrophy/interstitial fibrosis was the only feature independently associated with renal outcomes in Chinese children with IgAN.</p> |
topic |
Glomerulonephritis IgA nephropathy Oxford classification Children Pediatrics |
url |
http://www.biomedcentral.com/1471-2369/13/158 |
work_keys_str_mv |
AT leweibo validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT zengcaihong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT liuzhangsuo validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT liudong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT yangqing validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT linruixia validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT xiazhengkun validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT fanzhongmin validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT zhuguanghua validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT wuying validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT xuhong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT zhaiyihui validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT dingying validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT yangxiaoqing validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT liangshaoshan validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT chenhao validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT xufeng validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT huangqian validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT shenhongbing validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT wangjianming validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT fogoagnesb validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina AT liuzhihong validationoftheoxfordclassificationofiganephropathyforpediatricpatientsfromchina |
_version_ |
1725301717523759104 |